January 31, 2019 06:40 AM EST

FDA blesses Merck’s PhIII effort to topple a mega-blockbuster — but there’s also a little biotech in this game

Merck just got a leg up in its quest to leapfrog Pfizer’s best-selling pneumococcal conjugate vaccine Prevnar 13. The FDA is providing its

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

FDA bless­es Mer­ck’s PhI­II ef­fort to top­ple a mega-block­buster — but there’s al­so a lit­tle biotech in this game